Financial Markets
Real Estate
Local listed Company
Overseas-listed Company
Foreign Company
Industrial Parks

Stocks / IPOs
 Search News  Or
Shanghai Fosun Pharma to raise HK$4.6 bln via HK IPO

Oct. 17, 2012 (China Knowledge) - Shanghai Fosun Pharmaceutical (Group) Co<600196>, the medical subsidiary of Fosun International Ltd<0656>, China's largest privately-owned conglomerate, plans to start its initial public offering on the Hong Kong Stock Exchange with HK$4.6 billion or US$591 million fundraising.

According to prospectus, the medical manufacturer will issue 336 million shares at a price of between HK$11.8 and HK$13.68 apiece.

Two cornerstone investors will subscribe US$75 million worth of shares in the IPO. Prudential Insurance Co will invest US$50 million in the IPO, while International Finance Corp will spend US$25 million on share subscription.

UBS AG, China International Capital Corp, J.P. Morgan Chase & Co and Deutsche Bank AG will be responsible to arrange the IPO transaction.

Shanghai Fosun Pharmaceutical said it will be listed in Hong Kong on October 30.

Add this     
Copyright © "2015"

Send feedback or comments to:

For more news, financial weekly reports, business guides to China, Market Research Reports and other premium information, subscribe to China Knowledge today

To access our page on Bloomberg, type CKFI (GO)

 Our Professional Services


 News Archive
About Us | CSR | Media Center | E-Newsletter | E-Store | Contact Us | Feedback | Sitemap | Privacy Policy | Terms of Use  

           Copyright © 2014 China Knowledge Online. All Rights Reserved